Free access for registered Healthcare Professionals and home of "The Oncology Podcast"
Join us today for the latest oncology news, commentary, educational resources and podcasts
oncologynetwork.com.au
Earlier-day immunochemotherapy delivery may be associated with improved outcomes in advanced NSCLC
#LungCancer #NSCLC #Immunotherapy #Chemotherapy #Oncology #OncologyResearch #OncologyNews #CanSky #MedSky
Earlier-day immunochemotherapy delivery may be associated with improved outcomes in advanced NSCLC
#LungCancer #NSCLC #Immunotherapy #Chemotherapy #Oncology #OncologyResearch #OncologyNews #CanSky #MedSky
A/Prof Ben Dessauvagie & Prof Gelareh Farshid explore HER2 ultralow breast cancer, evolving pathology practice and implications for MDT decision-making.
🎧 Listen now: t.ly/3E4kJ | #BeyondtheSlide #HER2 #HER2Ultralow #Oncology#MedEd #BreastCancer
A/Prof Ben Dessauvagie & Prof Gelareh Farshid explore HER2 ultralow breast cancer, evolving pathology practice and implications for MDT decision-making.
🎧 Listen now: t.ly/3E4kJ | #BeyondtheSlide #HER2 #HER2Ultralow #Oncology#MedEd #BreastCancer
Dive into The Oncology Journal Club 🎧 S3E10: I am large, I contain multitudes!
Expert insights on cancer control measures, the microbiome & surprising research highlights. Thanks to @craigunderhill.bsky.social, Chris Jackson + Kate Clarke #OJC
Listen👉 t.ly/pmcHH
Dive into The Oncology Journal Club 🎧 S3E10: I am large, I contain multitudes!
Expert insights on cancer control measures, the microbiome & surprising research highlights. Thanks to @craigunderhill.bsky.social, Chris Jackson + Kate Clarke #OJC
Listen👉 t.ly/pmcHH
@drkiwikate.bsky.social takes over hosting duties as @craigunderhill.bsky.social covers GU + lung highlights, with a London Global Cancer Week preview from Christopher Jackson
Nuanced analysis, sharp insights + OJC banter! #OncologyPodcast
@drkiwikate.bsky.social takes over hosting duties as @craigunderhill.bsky.social covers GU + lung highlights, with a London Global Cancer Week preview from Christopher Jackson
Nuanced analysis, sharp insights + OJC banter! #OncologyPodcast
You can learn more about the program highlights in our Special Preview podcast here: t.ly/ly9fx #GICancer #GIOncology #CancerResearch #Collaboration #MedEd
You can learn more about the program highlights in our Special Preview podcast here: t.ly/ly9fx #GICancer #GIOncology #CancerResearch #Collaboration #MedEd
It’s ESMO Oncology Journal Club time! Part 1 t.ly/hk8pe
@craigunderhill.bsky.social, @drkiwikate.bsky.social & Christopher Jackson break down the abstracts from #ESMO2025
#OJC #MedEd #OncologyPodcast
It’s ESMO Oncology Journal Club time! Part 1 t.ly/hk8pe
@craigunderhill.bsky.social, @drkiwikate.bsky.social & Christopher Jackson break down the abstracts from #ESMO2025
#OJC #MedEd #OncologyPodcast
Listen here: t.ly/ZKF16 or wherever you get your podcasts| @agitg.bsky.social #GIcancer #CancerResearch #OncologyPodcast #Oncology
Listen here: t.ly/ZKF16 or wherever you get your podcasts| @agitg.bsky.social #GIcancer #CancerResearch #OncologyPodcast #Oncology
🧬 Non-op management of MMR-deficient tumours
📊 Clinical trial design standards
🎯 HER2-negative metastatic breast cancer
And much more! Listen now 👉 t.ly/XvKag
#Oncology #OncologyPodcast #MedEd #OJC #MedSky #OncSky #CanSky @craigunderhill.bsky.social
🧬 Non-op management of MMR-deficient tumours
📊 Clinical trial design standards
🎯 HER2-negative metastatic breast cancer
And much more! Listen now 👉 t.ly/XvKag
#Oncology #OncologyPodcast #MedEd #OJC #MedSky #OncSky #CanSky @craigunderhill.bsky.social
80% response rate in injected tumours in a Phase IIa soft tissue sarcoma trial using the novel drug tigilanol tiglate —a compound sourced from a rainforest plant🌿
🔗 oncologynews.com.au/tumour-strea...
#CancerResearch #RareCancers #CanSky #OncSky #MedSky #Cancer
80% response rate in injected tumours in a Phase IIa soft tissue sarcoma trial using the novel drug tigilanol tiglate —a compound sourced from a rainforest plant🌿
🔗 oncologynews.com.au/tumour-strea...
#CancerResearch #RareCancers #CanSky #OncSky #MedSky #Cancer
Join the OJC team for expert insights, sharp analysis & a dose of humour as they unpack the biggest stories from #ASCO25 #asco2025
👉 Listen: t.ly/h6hT- or via apps
#Oncology #CancerResearch #OJC #MedSky #OncSky #CanSky @craigunderhill.bsky.social
Join the OJC team for expert insights, sharp analysis & a dose of humour as they unpack the biggest stories from #ASCO25 #asco2025
👉 Listen: t.ly/h6hT- or via apps
#Oncology #CancerResearch #OJC #MedSky #OncSky #CanSky @craigunderhill.bsky.social
ASCO 2025 Special – Part 1 is here!
Join @craigunderhill.bsky.social, Dr Kate Clarke and Prof Christopher Jackson they unpack key highlights and hot topics from #ASCO25
Listen now 👉 oncologynews.com.au/events/s3e4-...
#Oncology #CancerResearch #ASCO2025 #OJC
ASCO 2025 Special – Part 1 is here!
Join @craigunderhill.bsky.social, Dr Kate Clarke and Prof Christopher Jackson they unpack key highlights and hot topics from #ASCO25
Listen now 👉 oncologynews.com.au/events/s3e4-...
#Oncology #CancerResearch #ASCO2025 #OJC
Is tissue the issue in #BRCA testing for advanced #ProstateCancer?
Rachael Babin chats to Fiona MacLean & Matthew Roberts to unpack tissue challenges & testing evolution
🎙️ Listen now: oncologynetwork.com.au/brca-testing...
#CanSky #OncSky #MedSky @astra-zeneca.bsky.social
Is tissue the issue in #BRCA testing for advanced #ProstateCancer?
Rachael Babin chats to Fiona MacLean & Matthew Roberts to unpack tissue challenges & testing evolution
🎙️ Listen now: oncologynetwork.com.au/brca-testing...
#CanSky #OncSky #MedSky @astra-zeneca.bsky.social
Why we must rethink care for those living “in the place in between.”
🎙️ Listen: t.ly/6ODFq
#Cancer #SupportiveCare #CanSky #OncSky #MedSky #MedEd
Why we must rethink care for those living “in the place in between.”
🎙️ Listen: t.ly/6ODFq
#Cancer #SupportiveCare #CanSky #OncSky #MedSky #MedEd
Explore how @MonashPCCC is advancing precision oncology + fostering equitable access for patients with #Cancer in #Victoria
Listen now 👉 t.ly/RiPv1 or via Youtube, Apple etc
#PrecisionOncology #Equity #SkyMed #CanMed #OncMed
Explore how @MonashPCCC is advancing precision oncology + fostering equitable access for patients with #Cancer in #Victoria
Listen now 👉 t.ly/RiPv1 or via Youtube, Apple etc
#PrecisionOncology #Equity #SkyMed #CanMed #OncMed
Prof Mark Shackleton joins us to discuss how the MPCCC is transforming cancer care access across Victoria—through molecular tumour boards, fellowships & more.
Don't miss it.
🎙️http://t.ly/dks3m
#Oncology #MPCCC #HealthcareEquity #CanSky #OncSky #MedSky
Listen here for a fresh and fun antipodean perspective: t.ly/be6Xx
Shout out to @eaeisenhauer.bsky.social @drjnaidoo.bsky.social + @ascocancer.bsky.social
#Cansky #Oncsky #Medsky
Listen here for a fresh and fun antipodean perspective: t.ly/be6Xx
Shout out to @eaeisenhauer.bsky.social @drjnaidoo.bsky.social + @ascocancer.bsky.social
#Cansky #Oncsky #Medsky
Join Prof Tim Price + Prof Jeanne Tie for an insightful discussion on BRAFV600E-mutant metastatic colorectal cancer
Listen: t.ly/vtbMy | #Oncology #Cancer #GICancer #GI #ColorectalCancer #BRAFV600E
Join Prof Tim Price + Prof Jeanne Tie for an insightful discussion on BRAFV600E-mutant metastatic colorectal cancer
Listen: t.ly/vtbMy | #Oncology #Cancer #GICancer #GI #ColorectalCancer #BRAFV600E
Explore the National Lung Cancer Screening Program, latest research and implementation strategies
For registration: vcccalliance.org.au/news-and-eve...
#LungCancer #LungCancerScreening #CanSky
@vcccalliance.bsky.social
Explore the National Lung Cancer Screening Program, latest research and implementation strategies
For registration: vcccalliance.org.au/news-and-eve...
#LungCancer #LungCancerScreening #CanSky
@vcccalliance.bsky.social